nodes	percent_of_prediction	percent_of_DWPC	metapath
Gentamicin—Kanamycin—Acarbose—type 2 diabetes mellitus	0.441	1	CrCrCtD
Gentamicin—SLC22A6—Chlorpropamide—type 2 diabetes mellitus	0.09	0.276	CbGbCtD
Gentamicin—SLC22A6—Tolbutamide—type 2 diabetes mellitus	0.0802	0.246	CbGbCtD
Gentamicin—SLC22A6—Nateglinide—type 2 diabetes mellitus	0.0682	0.209	CbGbCtD
Gentamicin—SLC22A6—Glyburide—type 2 diabetes mellitus	0.0461	0.141	CbGbCtD
Gentamicin—SLC22A6—Losartan—type 2 diabetes mellitus	0.0421	0.129	CbGbCtD
Gentamicin—LRP2—retina—type 2 diabetes mellitus	0.00468	0.236	CbGeAlD
Gentamicin—LRP2—nephron tubule—type 2 diabetes mellitus	0.0044	0.222	CbGeAlD
Gentamicin—LRP2—kidney—type 2 diabetes mellitus	0.00387	0.195	CbGeAlD
Gentamicin—LRP2—cortex of kidney—type 2 diabetes mellitus	0.00377	0.19	CbGeAlD
Gentamicin—SLC22A6—nephron tubule—type 2 diabetes mellitus	0.00166	0.0839	CbGeAlD
Gentamicin—SLC22A6—cortex of kidney—type 2 diabetes mellitus	0.00142	0.0718	CbGeAlD
Gentamicin—Vomiting—Nateglinide—type 2 diabetes mellitus	0.000265	0.00229	CcSEcCtD
Gentamicin—Rash—Nateglinide—type 2 diabetes mellitus	0.000263	0.00227	CcSEcCtD
Gentamicin—Dermatitis—Nateglinide—type 2 diabetes mellitus	0.000262	0.00227	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Pioglitazone—type 2 diabetes mellitus	0.00026	0.00225	CcSEcCtD
Gentamicin—Hypotension—Glimepiride—type 2 diabetes mellitus	0.00026	0.00225	CcSEcCtD
Gentamicin—Anaemia—Glyburide—type 2 diabetes mellitus	0.00026	0.00225	CcSEcCtD
Gentamicin—Decreased appetite—Glipizide—type 2 diabetes mellitus	0.000259	0.00224	CcSEcCtD
Gentamicin—Nausea—Acarbose—type 2 diabetes mellitus	0.000257	0.00222	CcSEcCtD
Gentamicin—Pruritus—Repaglinide—type 2 diabetes mellitus	0.000255	0.0022	CcSEcCtD
Gentamicin—Confusional state—Bromocriptine—type 2 diabetes mellitus	0.000253	0.00219	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Sitagliptin—type 2 diabetes mellitus	0.000253	0.00218	CcSEcCtD
Gentamicin—Erythema—Gliclazide—type 2 diabetes mellitus	0.000252	0.00218	CcSEcCtD
Gentamicin—Leukopenia—Glyburide—type 2 diabetes mellitus	0.000252	0.00218	CcSEcCtD
Gentamicin—Paraesthesia—Glimepiride—type 2 diabetes mellitus	0.00025	0.00216	CcSEcCtD
Gentamicin—Nausea—Nateglinide—type 2 diabetes mellitus	0.000247	0.00214	CcSEcCtD
Gentamicin—Feeling abnormal—Glipizide—type 2 diabetes mellitus	0.000246	0.00212	CcSEcCtD
Gentamicin—Convulsion—Glyburide—type 2 diabetes mellitus	0.000244	0.00211	CcSEcCtD
Gentamicin—Decreased appetite—Glimepiride—type 2 diabetes mellitus	0.000242	0.00209	CcSEcCtD
Gentamicin—Hypoaesthesia—Metformin—type 2 diabetes mellitus	0.000241	0.00209	CcSEcCtD
Gentamicin—Decreased appetite—Sitagliptin—type 2 diabetes mellitus	0.000241	0.00208	CcSEcCtD
Gentamicin—Pruritus—Rosiglitazone—type 2 diabetes mellitus	0.000241	0.00208	CcSEcCtD
Gentamicin—Arthralgia—Glyburide—type 2 diabetes mellitus	0.000239	0.00207	CcSEcCtD
Gentamicin—Agranulocytosis—Irbesartan—type 2 diabetes mellitus	0.000238	0.00206	CcSEcCtD
Gentamicin—Urticaria—Glipizide—type 2 diabetes mellitus	0.000237	0.00205	CcSEcCtD
Gentamicin—Alopecia—Valsartan—type 2 diabetes mellitus	0.000235	0.00204	CcSEcCtD
Gentamicin—Feeling abnormal—Pioglitazone—type 2 diabetes mellitus	0.000235	0.00203	CcSEcCtD
Gentamicin—Neuropathy peripheral—Losartan—type 2 diabetes mellitus	0.000235	0.00203	CcSEcCtD
Gentamicin—Hypotension—Bromocriptine—type 2 diabetes mellitus	0.000235	0.00203	CcSEcCtD
Gentamicin—Anaemia—Gliclazide—type 2 diabetes mellitus	0.000233	0.00202	CcSEcCtD
Gentamicin—Alopecia—Orlistat—type 2 diabetes mellitus	0.000233	0.00201	CcSEcCtD
Gentamicin—Confusional state—Glyburide—type 2 diabetes mellitus	0.000231	0.002	CcSEcCtD
Gentamicin—Feeling abnormal—Glimepiride—type 2 diabetes mellitus	0.000229	0.00198	CcSEcCtD
Gentamicin—Vomiting—Repaglinide—type 2 diabetes mellitus	0.000229	0.00198	CcSEcCtD
Gentamicin—Eosinophilia—Ramipril—type 2 diabetes mellitus	0.000229	0.00198	CcSEcCtD
Gentamicin—Feeling abnormal—Sitagliptin—type 2 diabetes mellitus	0.000229	0.00198	CcSEcCtD
Gentamicin—Hypoaesthesia—Irbesartan—type 2 diabetes mellitus	0.000228	0.00197	CcSEcCtD
Gentamicin—Rash—Repaglinide—type 2 diabetes mellitus	0.000227	0.00196	CcSEcCtD
Gentamicin—Dermatitis—Repaglinide—type 2 diabetes mellitus	0.000227	0.00196	CcSEcCtD
Gentamicin—Urticaria—Pioglitazone—type 2 diabetes mellitus	0.000227	0.00196	CcSEcCtD
Gentamicin—Leukopenia—Gliclazide—type 2 diabetes mellitus	0.000226	0.00195	CcSEcCtD
Gentamicin—Headache—Repaglinide—type 2 diabetes mellitus	0.000226	0.00195	CcSEcCtD
Gentamicin—Paraesthesia—Bromocriptine—type 2 diabetes mellitus	0.000225	0.00195	CcSEcCtD
Gentamicin—Dizziness—Rosiglitazone—type 2 diabetes mellitus	0.000225	0.00195	CcSEcCtD
Gentamicin—Thrombocytopenia—Glyburide—type 2 diabetes mellitus	0.000225	0.00194	CcSEcCtD
Gentamicin—Agranulocytosis—Losartan—type 2 diabetes mellitus	0.000224	0.00194	CcSEcCtD
Gentamicin—Urticaria—Glimepiride—type 2 diabetes mellitus	0.000221	0.00191	CcSEcCtD
Gentamicin—Visual impairment—Irbesartan—type 2 diabetes mellitus	0.000221	0.00191	CcSEcCtD
Gentamicin—Urticaria—Sitagliptin—type 2 diabetes mellitus	0.00022	0.0019	CcSEcCtD
Gentamicin—Hypersensitivity—Glipizide—type 2 diabetes mellitus	0.00022	0.0019	CcSEcCtD
Gentamicin—Convulsion—Gliclazide—type 2 diabetes mellitus	0.000219	0.00189	CcSEcCtD
Gentamicin—Decreased appetite—Bromocriptine—type 2 diabetes mellitus	0.000218	0.00189	CcSEcCtD
Gentamicin—Hypertension—Gliclazide—type 2 diabetes mellitus	0.000218	0.00188	CcSEcCtD
Gentamicin—Arthralgia—Gliclazide—type 2 diabetes mellitus	0.000215	0.00186	CcSEcCtD
Gentamicin—Rash—Rosiglitazone—type 2 diabetes mellitus	0.000215	0.00186	CcSEcCtD
Gentamicin—Dermatitis—Rosiglitazone—type 2 diabetes mellitus	0.000215	0.00185	CcSEcCtD
Gentamicin—Hypotension—Glyburide—type 2 diabetes mellitus	0.000214	0.00185	CcSEcCtD
Gentamicin—Hypoaesthesia—Losartan—type 2 diabetes mellitus	0.000214	0.00185	CcSEcCtD
Gentamicin—Nausea—Repaglinide—type 2 diabetes mellitus	0.000214	0.00185	CcSEcCtD
Gentamicin—Tinnitus—Irbesartan—type 2 diabetes mellitus	0.000214	0.00185	CcSEcCtD
Gentamicin—Headache—Rosiglitazone—type 2 diabetes mellitus	0.000213	0.00184	CcSEcCtD
Gentamicin—Erythema—Metformin—type 2 diabetes mellitus	0.000211	0.00183	CcSEcCtD
Gentamicin—Pruritus—Glipizide—type 2 diabetes mellitus	0.000211	0.00182	CcSEcCtD
Gentamicin—Hypersensitivity—Pioglitazone—type 2 diabetes mellitus	0.00021	0.00182	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Glyburide—type 2 diabetes mellitus	0.000209	0.00181	CcSEcCtD
Gentamicin—Vertigo—Valsartan—type 2 diabetes mellitus	0.000208	0.0018	CcSEcCtD
Gentamicin—Confusional state—Gliclazide—type 2 diabetes mellitus	0.000208	0.0018	CcSEcCtD
Gentamicin—Feeling abnormal—Bromocriptine—type 2 diabetes mellitus	0.000207	0.00179	CcSEcCtD
Gentamicin—Paraesthesia—Glyburide—type 2 diabetes mellitus	0.000206	0.00178	CcSEcCtD
Gentamicin—Vertigo—Orlistat—type 2 diabetes mellitus	0.000206	0.00178	CcSEcCtD
Gentamicin—Hypersensitivity—Glimepiride—type 2 diabetes mellitus	0.000205	0.00177	CcSEcCtD
Gentamicin—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000204	0.00177	CcSEcCtD
Gentamicin—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000202	0.00175	CcSEcCtD
Gentamicin—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	0.000202	0.00174	CcSEcCtD
Gentamicin—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	0.000202	0.00174	CcSEcCtD
Gentamicin—Tinnitus—Losartan—type 2 diabetes mellitus	0.000201	0.00174	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CYP1A2—type 2 diabetes mellitus	0.000201	0.00207	CbGpPWpGaD
Gentamicin—Stomatitis—Ramipril—type 2 diabetes mellitus	0.000201	0.00173	CcSEcCtD
Gentamicin—Decreased appetite—Glyburide—type 2 diabetes mellitus	0.0002	0.00172	CcSEcCtD
Gentamicin—Urticaria—Bromocriptine—type 2 diabetes mellitus	0.000199	0.00172	CcSEcCtD
Gentamicin—Erythema—Irbesartan—type 2 diabetes mellitus	0.000199	0.00172	CcSEcCtD
Gentamicin—Convulsion—Orlistat—type 2 diabetes mellitus	0.000199	0.00172	CcSEcCtD
Gentamicin—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000198	0.00172	CcSEcCtD
Gentamicin—Arthralgia—Valsartan—type 2 diabetes mellitus	0.000198	0.00171	CcSEcCtD
Gentamicin—Dizziness—Glipizide—type 2 diabetes mellitus	0.000197	0.0017	CcSEcCtD
Gentamicin—LRP2—Metabolism—OXCT1—type 2 diabetes mellitus	0.000197	0.00203	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYTB—type 2 diabetes mellitus	0.000197	0.00203	CbGpPWpGaD
Gentamicin—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000197	0.0017	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	0.000197	0.00203	CbGpPWpGaD
Gentamicin—Hypotension—Gliclazide—type 2 diabetes mellitus	0.000193	0.00166	CcSEcCtD
Gentamicin—Agranulocytosis—Ramipril—type 2 diabetes mellitus	0.000192	0.00166	CcSEcCtD
Gentamicin—LRP2—Metabolism—SRD5A1—type 2 diabetes mellitus	0.000192	0.00198	CbGpPWpGaD
Gentamicin—Alopecia—Losartan—type 2 diabetes mellitus	0.00019	0.00165	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	0.00019	0.00196	CbGpPWpGaD
Gentamicin—Vomiting—Glipizide—type 2 diabetes mellitus	0.00019	0.00164	CcSEcCtD
Gentamicin—Anaphylactic shock—Valsartan—type 2 diabetes mellitus	0.000189	0.00164	CcSEcCtD
Gentamicin—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000189	0.00163	CcSEcCtD
Gentamicin—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000189	0.00163	CcSEcCtD
Gentamicin—Rash—Glipizide—type 2 diabetes mellitus	0.000188	0.00162	CcSEcCtD
Gentamicin—Dermatitis—Glipizide—type 2 diabetes mellitus	0.000188	0.00162	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	0.000188	0.00162	CcSEcCtD
Gentamicin—Erythema—Losartan—type 2 diabetes mellitus	0.000188	0.00162	CcSEcCtD
Gentamicin—Anaphylactic shock—Orlistat—type 2 diabetes mellitus	0.000187	0.00162	CcSEcCtD
Gentamicin—Headache—Glipizide—type 2 diabetes mellitus	0.000187	0.00161	CcSEcCtD
Gentamicin—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	0.000185	0.0016	CcSEcCtD
Gentamicin—Paraesthesia—Gliclazide—type 2 diabetes mellitus	0.000185	0.0016	CcSEcCtD
Gentamicin—Anaemia—Irbesartan—type 2 diabetes mellitus	0.000184	0.00159	CcSEcCtD
Gentamicin—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000184	0.00159	CcSEcCtD
Gentamicin—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000183	0.00159	CcSEcCtD
Gentamicin—LRP2—Disease—PCK1—type 2 diabetes mellitus	0.000183	0.00189	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ACACA—type 2 diabetes mellitus	0.000183	0.00189	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—STAR—type 2 diabetes mellitus	0.000183	0.00189	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HSD17B3—type 2 diabetes mellitus	0.000183	0.00189	CbGpPWpGaD
Gentamicin—Hypertension—Metformin—type 2 diabetes mellitus	0.000182	0.00158	CcSEcCtD
Gentamicin—Urticaria—Glyburide—type 2 diabetes mellitus	0.000182	0.00158	CcSEcCtD
Gentamicin—Vertigo—Irbesartan—type 2 diabetes mellitus	0.000179	0.00155	CcSEcCtD
Gentamicin—Headache—Pioglitazone—type 2 diabetes mellitus	0.000179	0.00155	CcSEcCtD
Gentamicin—Leukopenia—Irbesartan—type 2 diabetes mellitus	0.000178	0.00154	CcSEcCtD
Gentamicin—LRP2—Disease—TLE4—type 2 diabetes mellitus	0.000178	0.00184	CbGpPWpGaD
Gentamicin—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000178	0.00154	CcSEcCtD
Gentamicin—Nausea—Glipizide—type 2 diabetes mellitus	0.000177	0.00153	CcSEcCtD
Gentamicin—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000177	0.00153	CcSEcCtD
Gentamicin—Hypotension—Valsartan—type 2 diabetes mellitus	0.000177	0.00153	CcSEcCtD
Gentamicin—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000176	0.00152	CcSEcCtD
Gentamicin—LRP2—Metabolism—ABCC8—type 2 diabetes mellitus	0.000176	0.00181	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CBS—type 2 diabetes mellitus	0.000176	0.00181	CbGpPWpGaD
Gentamicin—Rash—Glimepiride—type 2 diabetes mellitus	0.000175	0.00152	CcSEcCtD
Gentamicin—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000175	0.00151	CcSEcCtD
Gentamicin—Rash—Sitagliptin—type 2 diabetes mellitus	0.000175	0.00151	CcSEcCtD
Gentamicin—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000175	0.00151	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GCGR—type 2 diabetes mellitus	0.000174	0.0018	CbGpPWpGaD
Gentamicin—Headache—Glimepiride—type 2 diabetes mellitus	0.000174	0.00151	CcSEcCtD
Gentamicin—Headache—Sitagliptin—type 2 diabetes mellitus	0.000174	0.0015	CcSEcCtD
Gentamicin—Anaemia—Losartan—type 2 diabetes mellitus	0.000173	0.0015	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	0.000172	0.00149	CcSEcCtD
Gentamicin—Tinnitus—Ramipril—type 2 diabetes mellitus	0.000172	0.00149	CcSEcCtD
Gentamicin—Hypertension—Irbesartan—type 2 diabetes mellitus	0.000172	0.00149	CcSEcCtD
Gentamicin—LRP2—Disease—HK1—type 2 diabetes mellitus	0.000172	0.00177	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	0.00017	0.00147	CcSEcCtD
Gentamicin—Paraesthesia—Valsartan—type 2 diabetes mellitus	0.00017	0.00147	CcSEcCtD
Gentamicin—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.00017	0.00147	CcSEcCtD
Gentamicin—Arthralgia—Irbesartan—type 2 diabetes mellitus	0.00017	0.00147	CcSEcCtD
Gentamicin—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000169	0.00146	CcSEcCtD
Gentamicin—LRP2—Metabolism—COX2—type 2 diabetes mellitus	0.000169	0.00174	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SLC5A2—type 2 diabetes mellitus	0.000169	0.00174	CbGpPWpGaD
Gentamicin—Thrombocytopenia—Metformin—type 2 diabetes mellitus	0.000169	0.00146	CcSEcCtD
Gentamicin—Vertigo—Losartan—type 2 diabetes mellitus	0.000169	0.00146	CcSEcCtD
Gentamicin—Paraesthesia—Orlistat—type 2 diabetes mellitus	0.000168	0.00145	CcSEcCtD
Gentamicin—Leukopenia—Losartan—type 2 diabetes mellitus	0.000168	0.00145	CcSEcCtD
Gentamicin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A4—type 2 diabetes mellitus	0.000166	0.00172	CbGpPWpGaD
Gentamicin—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000166	0.00143	CcSEcCtD
Gentamicin—LRP2—Metabolism—NCOA6—type 2 diabetes mellitus	0.000166	0.00171	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPARGC1A—type 2 diabetes mellitus	0.000166	0.00171	CbGpPWpGaD
Gentamicin—LRP2—Disease—GCKR—type 2 diabetes mellitus	0.000166	0.00171	CbGpPWpGaD
Gentamicin—Nausea—Glimepiride—type 2 diabetes mellitus	0.000165	0.00143	CcSEcCtD
Gentamicin—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000165	0.00142	CcSEcCtD
Gentamicin—Decreased appetite—Valsartan—type 2 diabetes mellitus	0.000165	0.00142	CcSEcCtD
Gentamicin—Urticaria—Gliclazide—type 2 diabetes mellitus	0.000164	0.00141	CcSEcCtD
Gentamicin—Alopecia—Ramipril—type 2 diabetes mellitus	0.000163	0.00141	CcSEcCtD
Gentamicin—LRP2—Metabolism—UCP2—type 2 diabetes mellitus	0.000163	0.00168	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HSD11B1—type 2 diabetes mellitus	0.000163	0.00168	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—UCP3—type 2 diabetes mellitus	0.000163	0.00168	CbGpPWpGaD
Gentamicin—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000163	0.00141	CcSEcCtD
Gentamicin—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	0.000163	0.00141	CcSEcCtD
Gentamicin—Decreased appetite—Orlistat—type 2 diabetes mellitus	0.000163	0.00141	CcSEcCtD
Gentamicin—Pruritus—Glyburide—type 2 diabetes mellitus	0.000162	0.0014	CcSEcCtD
Gentamicin—Hypotension—Metformin—type 2 diabetes mellitus	0.000161	0.00139	CcSEcCtD
Gentamicin—Erythema—Ramipril—type 2 diabetes mellitus	0.000161	0.00139	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GRK5—type 2 diabetes mellitus	0.00016	0.00166	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GIPR—type 2 diabetes mellitus	0.00016	0.00166	CbGpPWpGaD
Gentamicin—Arthralgia—Losartan—type 2 diabetes mellitus	0.00016	0.00138	CcSEcCtD
Gentamicin—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.00016	0.00138	CcSEcCtD
Gentamicin—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	0.000159	0.00138	CcSEcCtD
Gentamicin—LRP2—Disease—ALDOB—type 2 diabetes mellitus	0.000159	0.00164	CbGpPWpGaD
Gentamicin—Rash—Bromocriptine—type 2 diabetes mellitus	0.000158	0.00137	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOB—type 2 diabetes mellitus	0.000158	0.00163	CbGpPWpGaD
Gentamicin—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000158	0.00137	CcSEcCtD
Gentamicin—Headache—Bromocriptine—type 2 diabetes mellitus	0.000157	0.00136	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	0.000157	0.00136	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	0.000155	0.0016	CbGpPWpGaD
Gentamicin—Paraesthesia—Metformin—type 2 diabetes mellitus	0.000155	0.00134	CcSEcCtD
Gentamicin—Confusional state—Losartan—type 2 diabetes mellitus	0.000154	0.00133	CcSEcCtD
Gentamicin—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000154	0.00133	CcSEcCtD
Gentamicin—LRP2—Metabolism—PCK1—type 2 diabetes mellitus	0.000153	0.00158	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Losartan—type 2 diabetes mellitus	0.000153	0.00132	CcSEcCtD
Gentamicin—Hypotension—Irbesartan—type 2 diabetes mellitus	0.000152	0.00131	CcSEcCtD
Gentamicin—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000152	0.00131	CcSEcCtD
Gentamicin—LRP2—Disease—SPRY2—type 2 diabetes mellitus	0.000152	0.00156	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—LPL—type 2 diabetes mellitus	0.000151	0.00156	CbGpPWpGaD
Gentamicin—Urticaria—Valsartan—type 2 diabetes mellitus	0.00015	0.0013	CcSEcCtD
Gentamicin—Thrombocytopenia—Losartan—type 2 diabetes mellitus	0.00015	0.0013	CcSEcCtD
Gentamicin—Decreased appetite—Metformin—type 2 diabetes mellitus	0.00015	0.0013	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.00015	0.00155	CbGpPWpGaD
Gentamicin—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000149	0.00129	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	0.000149	0.00154	CbGpPWpGaD
Gentamicin—Urticaria—Orlistat—type 2 diabetes mellitus	0.000149	0.00128	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	0.000148	0.00128	CcSEcCtD
Gentamicin—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000148	0.00128	CcSEcCtD
Gentamicin—LRP2—Disease—RBP4—type 2 diabetes mellitus	0.000148	0.00152	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—GPX1—type 2 diabetes mellitus	0.000147	0.00152	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MC4R—type 2 diabetes mellitus	0.000147	0.00151	CbGpPWpGaD
Gentamicin—Paraesthesia—Irbesartan—type 2 diabetes mellitus	0.000146	0.00126	CcSEcCtD
Gentamicin—Vomiting—Glyburide—type 2 diabetes mellitus	0.000146	0.00126	CcSEcCtD
Gentamicin—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000146	0.00126	CcSEcCtD
Gentamicin—Rash—Glyburide—type 2 diabetes mellitus	0.000145	0.00125	CcSEcCtD
Gentamicin—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000145	0.00125	CcSEcCtD
Gentamicin—Vertigo—Ramipril—type 2 diabetes mellitus	0.000145	0.00125	CcSEcCtD
Gentamicin—Leukopenia—Ramipril—type 2 diabetes mellitus	0.000144	0.00124	CcSEcCtD
Gentamicin—Headache—Glyburide—type 2 diabetes mellitus	0.000144	0.00124	CcSEcCtD
Gentamicin—LRP2—Metabolism—HK1—type 2 diabetes mellitus	0.000144	0.00148	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—CD36—type 2 diabetes mellitus	0.000144	0.00148	CbGpPWpGaD
Gentamicin—Hypotension—Losartan—type 2 diabetes mellitus	0.000143	0.00124	CcSEcCtD
Gentamicin—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000142	0.00123	CcSEcCtD
Gentamicin—Decreased appetite—Irbesartan—type 2 diabetes mellitus	0.000141	0.00122	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—GIP—type 2 diabetes mellitus	0.000141	0.00146	CbGpPWpGaD
Gentamicin—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	0.00014	0.00121	CcSEcCtD
Gentamicin—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000139	0.00121	CcSEcCtD
Gentamicin—Convulsion—Ramipril—type 2 diabetes mellitus	0.000139	0.0012	CcSEcCtD
Gentamicin—LRP2—Metabolism—HSD3B2—type 2 diabetes mellitus	0.000139	0.00143	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—KCNJ11—type 2 diabetes mellitus	0.000139	0.00143	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—LPA—type 2 diabetes mellitus	0.000139	0.00143	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GCKR—type 2 diabetes mellitus	0.000139	0.00143	CbGpPWpGaD
Gentamicin—LRP2—Disease—SLC2A2—type 2 diabetes mellitus	0.000138	0.00142	CbGpPWpGaD
Gentamicin—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000138	0.00119	CcSEcCtD
Gentamicin—Paraesthesia—Losartan—type 2 diabetes mellitus	0.000137	0.00119	CcSEcCtD
Gentamicin—Urticaria—Metformin—type 2 diabetes mellitus	0.000137	0.00118	CcSEcCtD
Gentamicin—Arthralgia—Ramipril—type 2 diabetes mellitus	0.000137	0.00118	CcSEcCtD
Gentamicin—Nausea—Glyburide—type 2 diabetes mellitus	0.000136	0.00118	CcSEcCtD
Gentamicin—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000136	0.00118	CcSEcCtD
Gentamicin—LRP2—Disease—MTR—type 2 diabetes mellitus	0.000135	0.00139	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LEPR—type 2 diabetes mellitus	0.000134	0.00139	CbGpPWpGaD
Gentamicin—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000134	0.00116	CcSEcCtD
Gentamicin—Pruritus—Valsartan—type 2 diabetes mellitus	0.000134	0.00116	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPARA—type 2 diabetes mellitus	0.000133	0.00138	CbGpPWpGaD
Gentamicin—Decreased appetite—Losartan—type 2 diabetes mellitus	0.000133	0.00115	CcSEcCtD
Gentamicin—LRP2—Metabolism—ALDOB—type 2 diabetes mellitus	0.000133	0.00137	CbGpPWpGaD
Gentamicin—LRP2—Disease—NAMPT—type 2 diabetes mellitus	0.000132	0.00137	CbGpPWpGaD
Gentamicin—Confusional state—Ramipril—type 2 diabetes mellitus	0.000132	0.00114	CcSEcCtD
Gentamicin—Pruritus—Orlistat—type 2 diabetes mellitus	0.000132	0.00114	CcSEcCtD
Gentamicin—LRP2—Disease—GCK—type 2 diabetes mellitus	0.000132	0.00136	CbGpPWpGaD
Gentamicin—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	0.000131	0.00113	CcSEcCtD
Gentamicin—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000131	0.00113	CcSEcCtD
Gentamicin—LRP2—Disease—IAPP—type 2 diabetes mellitus	0.000131	0.00135	CbGpPWpGaD
Gentamicin—Rash—Gliclazide—type 2 diabetes mellitus	0.00013	0.00112	CcSEcCtD
Gentamicin—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.00013	0.00112	CcSEcCtD
Gentamicin—Urticaria—Irbesartan—type 2 diabetes mellitus	0.000129	0.00112	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—AGT—type 2 diabetes mellitus	0.000129	0.00133	CbGpPWpGaD
Gentamicin—Headache—Gliclazide—type 2 diabetes mellitus	0.000129	0.00112	CcSEcCtD
Gentamicin—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000129	0.00111	CcSEcCtD
Gentamicin—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	0.000129	0.00111	CcSEcCtD
Gentamicin—LRP2—Disease—SLC9A1—type 2 diabetes mellitus	0.000128	0.00133	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	0.000128	0.00132	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	0.000127	0.00131	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOE—type 2 diabetes mellitus	0.000127	0.00131	CbGpPWpGaD
Gentamicin—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000126	0.00109	CcSEcCtD
Gentamicin—Dizziness—Valsartan—type 2 diabetes mellitus	0.000125	0.00108	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—APOA1—type 2 diabetes mellitus	0.000125	0.00129	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TLE4—type 2 diabetes mellitus	0.000125	0.00129	CbGpPWpGaD
Gentamicin—Dizziness—Orlistat—type 2 diabetes mellitus	0.000124	0.00107	CcSEcCtD
Gentamicin—LRP2—Metabolism—GLP1R—type 2 diabetes mellitus	0.000124	0.00128	CbGpPWpGaD
Gentamicin—Hypotension—Ramipril—type 2 diabetes mellitus	0.000123	0.00106	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	0.000122	0.00126	CbGpPWpGaD
Gentamicin—Nausea—Gliclazide—type 2 diabetes mellitus	0.000122	0.00106	CcSEcCtD
Gentamicin—Pruritus—Metformin—type 2 diabetes mellitus	0.000122	0.00105	CcSEcCtD
Gentamicin—Urticaria—Losartan—type 2 diabetes mellitus	0.000122	0.00105	CcSEcCtD
Gentamicin—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000121	0.00105	CcSEcCtD
Gentamicin—LRP2—Disease—HMGA1—type 2 diabetes mellitus	0.00012	0.00124	CbGpPWpGaD
Gentamicin—Vomiting—Valsartan—type 2 diabetes mellitus	0.00012	0.00104	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ADRB3—type 2 diabetes mellitus	0.00012	0.00124	CbGpPWpGaD
Gentamicin—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00012	0.00104	CcSEcCtD
Gentamicin—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	0.00012	0.00103	CcSEcCtD
Gentamicin—Rash—Valsartan—type 2 diabetes mellitus	0.000119	0.00103	CcSEcCtD
Gentamicin—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000119	0.00103	CcSEcCtD
Gentamicin—Vomiting—Orlistat—type 2 diabetes mellitus	0.000119	0.00103	CcSEcCtD
Gentamicin—Headache—Valsartan—type 2 diabetes mellitus	0.000119	0.00103	CcSEcCtD
Gentamicin—LRP2—Disease—SNAP25—type 2 diabetes mellitus	0.000118	0.00122	CbGpPWpGaD
Gentamicin—LRP2—Disease—PSMD6—type 2 diabetes mellitus	0.000118	0.00122	CbGpPWpGaD
Gentamicin—Rash—Orlistat—type 2 diabetes mellitus	0.000118	0.00102	CcSEcCtD
Gentamicin—Paraesthesia—Ramipril—type 2 diabetes mellitus	0.000118	0.00102	CcSEcCtD
Gentamicin—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000118	0.00102	CcSEcCtD
Gentamicin—Headache—Orlistat—type 2 diabetes mellitus	0.000117	0.00101	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CRHR1—type 2 diabetes mellitus	0.000116	0.0012	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SLC2A2—type 2 diabetes mellitus	0.000115	0.00119	CbGpPWpGaD
Gentamicin—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000115	0.000995	CcSEcCtD
Gentamicin—LRP2—Disease—CYBA—type 2 diabetes mellitus	0.000114	0.00118	CbGpPWpGaD
Gentamicin—Decreased appetite—Ramipril—type 2 diabetes mellitus	0.000114	0.000986	CcSEcCtD
Gentamicin—Dizziness—Metformin—type 2 diabetes mellitus	0.000114	0.000985	CcSEcCtD
Gentamicin—LRP2—Metabolism—MTR—type 2 diabetes mellitus	0.000113	0.00117	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CPT1A—type 2 diabetes mellitus	0.000113	0.00117	CbGpPWpGaD
Gentamicin—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.000113	0.000975	CcSEcCtD
Gentamicin—Nausea—Valsartan—type 2 diabetes mellitus	0.000112	0.000972	CcSEcCtD
Gentamicin—Nausea—Orlistat—type 2 diabetes mellitus	0.000111	0.00096	CcSEcCtD
Gentamicin—LRP2—Metabolism—NAMPT—type 2 diabetes mellitus	0.000111	0.00114	CbGpPWpGaD
Gentamicin—LRP2—Disease—CALCA—type 2 diabetes mellitus	0.000111	0.00114	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PPARG—type 2 diabetes mellitus	0.00011	0.00114	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—LIPC—type 2 diabetes mellitus	0.00011	0.00114	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HBA1—type 2 diabetes mellitus	0.00011	0.00114	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GCK—type 2 diabetes mellitus	0.00011	0.00114	CbGpPWpGaD
Gentamicin—Vomiting—Metformin—type 2 diabetes mellitus	0.00011	0.000947	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP11A1—type 2 diabetes mellitus	0.00011	0.00113	CbGpPWpGaD
Gentamicin—Rash—Metformin—type 2 diabetes mellitus	0.000109	0.000939	CcSEcCtD
Gentamicin—Dermatitis—Metformin—type 2 diabetes mellitus	0.000109	0.000939	CcSEcCtD
Gentamicin—Pruritus—Losartan—type 2 diabetes mellitus	0.000108	0.000936	CcSEcCtD
Gentamicin—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000108	0.000935	CcSEcCtD
Gentamicin—Headache—Metformin—type 2 diabetes mellitus	0.000108	0.000933	CcSEcCtD
Gentamicin—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000108	0.00093	CcSEcCtD
Gentamicin—LRP2—Metabolism—SLC9A1—type 2 diabetes mellitus	0.000108	0.00111	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	0.000107	0.00111	CbGpPWpGaD
Gentamicin—LRP2—Disease—SLC2A1—type 2 diabetes mellitus	0.000107	0.0011	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CETP—type 2 diabetes mellitus	0.000106	0.0011	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	0.000106	0.0011	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SPRY2—type 2 diabetes mellitus	0.000106	0.0011	CbGpPWpGaD
Gentamicin—LRP2—Disease—NOS1—type 2 diabetes mellitus	0.000105	0.00109	CbGpPWpGaD
Gentamicin—Urticaria—Ramipril—type 2 diabetes mellitus	0.000104	0.000901	CcSEcCtD
Gentamicin—LRP2—Disease—TCF7L2—type 2 diabetes mellitus	0.000104	0.00107	CbGpPWpGaD
Gentamicin—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000104	0.000897	CcSEcCtD
Gentamicin—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000103	0.000894	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—RBP4—type 2 diabetes mellitus	0.000103	0.00107	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GLP1R—type 2 diabetes mellitus	0.000103	0.00107	CbGpPWpGaD
Gentamicin—Rash—Irbesartan—type 2 diabetes mellitus	0.000103	0.000887	CcSEcCtD
Gentamicin—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000102	0.000886	CcSEcCtD
Gentamicin—Nausea—Metformin—type 2 diabetes mellitus	0.000102	0.000885	CcSEcCtD
Gentamicin—LRP2—Disease—SLC2A4—type 2 diabetes mellitus	0.000102	0.00106	CbGpPWpGaD
Gentamicin—Headache—Irbesartan—type 2 diabetes mellitus	0.000102	0.000881	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	0.000102	0.00105	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCKAR—type 2 diabetes mellitus	0.000102	0.00105	CbGpPWpGaD
Gentamicin—Dizziness—Losartan—type 2 diabetes mellitus	0.000101	0.000875	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.0001	0.00103	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—ALB—type 2 diabetes mellitus	9.92e-05	0.00102	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PSMD6—type 2 diabetes mellitus	9.89e-05	0.00102	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SNAP25—type 2 diabetes mellitus	9.89e-05	0.00102	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SREBF1—type 2 diabetes mellitus	9.89e-05	0.00102	CbGpPWpGaD
Gentamicin—Vomiting—Losartan—type 2 diabetes mellitus	9.74e-05	0.000841	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	9.72e-05	0.001	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CTGF—type 2 diabetes mellitus	9.7e-05	0.001	CbGpPWpGaD
Gentamicin—Hypersensitivity—Ramipril—type 2 diabetes mellitus	9.67e-05	0.000836	CcSEcCtD
Gentamicin—Nausea—Irbesartan—type 2 diabetes mellitus	9.66e-05	0.000835	CcSEcCtD
Gentamicin—Rash—Losartan—type 2 diabetes mellitus	9.65e-05	0.000834	CcSEcCtD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	9.65e-05	0.000996	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	9.65e-05	0.000996	CbGpPWpGaD
Gentamicin—Dermatitis—Losartan—type 2 diabetes mellitus	9.65e-05	0.000834	CcSEcCtD
Gentamicin—LRP2—Metabolism—HMGCR—type 2 diabetes mellitus	9.62e-05	0.000993	CbGpPWpGaD
Gentamicin—Headache—Losartan—type 2 diabetes mellitus	9.59e-05	0.000829	CcSEcCtD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	9.49e-05	0.00098	CbGpPWpGaD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PIK3R1—type 2 diabetes mellitus	9.49e-05	0.000979	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ADRA2A—type 2 diabetes mellitus	9.41e-05	0.000971	CbGpPWpGaD
Gentamicin—Pruritus—Ramipril—type 2 diabetes mellitus	9.29e-05	0.000803	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	9.22e-05	0.000951	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IAPP—type 2 diabetes mellitus	9.16e-05	0.000945	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—INSR—type 2 diabetes mellitus	9.1e-05	0.00094	CbGpPWpGaD
Gentamicin—Nausea—Losartan—type 2 diabetes mellitus	9.1e-05	0.000786	CcSEcCtD
Gentamicin—LRP2—Metabolism—CYP2E1—type 2 diabetes mellitus	9.04e-05	0.000933	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TRPC6—type 2 diabetes mellitus	8.94e-05	0.000923	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SLC2A1—type 2 diabetes mellitus	8.94e-05	0.000923	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP1A2—type 2 diabetes mellitus	8.94e-05	0.000923	CbGpPWpGaD
Gentamicin—LRP2—Disease—TGFBR2—type 2 diabetes mellitus	8.91e-05	0.000919	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AGTR2—type 2 diabetes mellitus	8.89e-05	0.000918	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	8.83e-05	0.000911	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CYP3A4—type 2 diabetes mellitus	8.72e-05	0.0009	CbGpPWpGaD
Gentamicin—Dizziness—Ramipril—type 2 diabetes mellitus	8.68e-05	0.00075	CcSEcCtD
Gentamicin—LRP2—Metabolism of lipids and lipoproteins—PTGS2—type 2 diabetes mellitus	8.68e-05	0.000895	CbGpPWpGaD
Gentamicin—LRP2—Disease—CDKN2B—type 2 diabetes mellitus	8.63e-05	0.00089	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—SLC2A4—type 2 diabetes mellitus	8.57e-05	0.000885	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GCG—type 2 diabetes mellitus	8.57e-05	0.000885	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EDNRB—type 2 diabetes mellitus	8.52e-05	0.000879	CbGpPWpGaD
Gentamicin—LRP2—Disease—APOB—type 2 diabetes mellitus	8.41e-05	0.000868	CbGpPWpGaD
Gentamicin—Vomiting—Ramipril—type 2 diabetes mellitus	8.35e-05	0.000721	CcSEcCtD
Gentamicin—Rash—Ramipril—type 2 diabetes mellitus	8.28e-05	0.000715	CcSEcCtD
Gentamicin—Dermatitis—Ramipril—type 2 diabetes mellitus	8.27e-05	0.000715	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—HTR2C—type 2 diabetes mellitus	8.27e-05	0.000853	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PSMD6—type 2 diabetes mellitus	8.27e-05	0.000853	CbGpPWpGaD
Gentamicin—Headache—Ramipril—type 2 diabetes mellitus	8.23e-05	0.000711	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—EDNRA—type 2 diabetes mellitus	8.04e-05	0.00083	CbGpPWpGaD
Gentamicin—LRP2—Disease—LPL—type 2 diabetes mellitus	8.03e-05	0.000829	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CYBA—type 2 diabetes mellitus	8.01e-05	0.000826	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	7.89e-05	0.000814	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	7.87e-05	0.000812	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	7.87e-05	0.000812	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	7.87e-05	0.000812	CbGpPWpGaD
Gentamicin—LRP2—Disease—ADCY5—type 2 diabetes mellitus	7.86e-05	0.000812	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PLAT—type 2 diabetes mellitus	7.84e-05	0.000809	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GHRL—type 2 diabetes mellitus	7.84e-05	0.000809	CbGpPWpGaD
Gentamicin—Nausea—Ramipril—type 2 diabetes mellitus	7.8e-05	0.000674	CcSEcCtD
Gentamicin—LRP2—Signaling Pathways—CALCA—type 2 diabetes mellitus	7.74e-05	0.000799	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	7.58e-05	0.000782	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	7.58e-05	0.000782	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	7.56e-05	0.000781	CbGpPWpGaD
Gentamicin—LRP2—Disease—PPP2CA—type 2 diabetes mellitus	7.54e-05	0.000778	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	7.44e-05	0.000768	CbGpPWpGaD
Gentamicin—LRP2—Disease—CCR5—type 2 diabetes mellitus	7.4e-05	0.000764	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PPARGC1A—type 2 diabetes mellitus	7.39e-05	0.000763	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GNB3—type 2 diabetes mellitus	7.39e-05	0.000763	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—HMOX1—type 2 diabetes mellitus	7.35e-05	0.000759	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	7.29e-05	0.000753	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CAT—type 2 diabetes mellitus	7.26e-05	0.000749	CbGpPWpGaD
Gentamicin—LRP2—Disease—MTHFR—type 2 diabetes mellitus	7.23e-05	0.000746	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PTPN1—type 2 diabetes mellitus	7.17e-05	0.00074	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GCG—type 2 diabetes mellitus	7.17e-05	0.00074	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	7.05e-05	0.000728	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—APOB—type 2 diabetes mellitus	7.05e-05	0.000727	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	7.03e-05	0.000726	CbGpPWpGaD
Gentamicin—LRP2—Disease—HIF1A—type 2 diabetes mellitus	6.9e-05	0.000712	CbGpPWpGaD
Gentamicin—LRP2—Disease—IRS2—type 2 diabetes mellitus	6.88e-05	0.00071	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	6.88e-05	0.00071	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GSTM1—type 2 diabetes mellitus	6.85e-05	0.000707	CbGpPWpGaD
Gentamicin—LRP2—Disease—CALM1—type 2 diabetes mellitus	6.76e-05	0.000697	CbGpPWpGaD
Gentamicin—LRP2—Disease—APOE—type 2 diabetes mellitus	6.73e-05	0.000695	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—LPL—type 2 diabetes mellitus	6.73e-05	0.000694	CbGpPWpGaD
Gentamicin—LRP2—Disease—APOA1—type 2 diabetes mellitus	6.66e-05	0.000687	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ADCY5—type 2 diabetes mellitus	6.59e-05	0.00068	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—GPX1—type 2 diabetes mellitus	6.56e-05	0.000677	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	6.44e-05	0.000665	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	6.43e-05	0.000664	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CD36—type 2 diabetes mellitus	6.39e-05	0.00066	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PPP2CA—type 2 diabetes mellitus	6.31e-05	0.000651	CbGpPWpGaD
Gentamicin—LRP2—Disease—NOS2—type 2 diabetes mellitus	6.27e-05	0.000648	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	6.24e-05	0.000644	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	6.22e-05	0.000642	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—GNB3—type 2 diabetes mellitus	6.18e-05	0.000638	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AVP—type 2 diabetes mellitus	6.09e-05	0.000629	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP3—type 2 diabetes mellitus	6.09e-05	0.000629	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IGF2—type 2 diabetes mellitus	6.07e-05	0.000626	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—MTHFR—type 2 diabetes mellitus	6.06e-05	0.000625	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	6.04e-05	0.000624	CbGpPWpGaD
Gentamicin—LRP2—Disease—IRS1—type 2 diabetes mellitus	6.01e-05	0.00062	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	5.96e-05	0.000616	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PPARA—type 2 diabetes mellitus	5.94e-05	0.000613	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APOB—type 2 diabetes mellitus	5.89e-05	0.000608	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IGF1R—type 2 diabetes mellitus	5.87e-05	0.000606	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EDN1—type 2 diabetes mellitus	5.8e-05	0.000598	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AGT—type 2 diabetes mellitus	5.75e-05	0.000594	CbGpPWpGaD
Gentamicin—LRP2—Disease—INS—type 2 diabetes mellitus	5.75e-05	0.000594	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—CALM1—type 2 diabetes mellitus	5.66e-05	0.000584	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—APOE—type 2 diabetes mellitus	5.64e-05	0.000582	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LPL—type 2 diabetes mellitus	5.62e-05	0.000581	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—APOA1—type 2 diabetes mellitus	5.57e-05	0.000575	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT2—type 2 diabetes mellitus	5.56e-05	0.000574	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—ADCY5—type 2 diabetes mellitus	5.51e-05	0.000568	CbGpPWpGaD
Gentamicin—LRP2—Disease—SERPINE1—type 2 diabetes mellitus	5.28e-05	0.000545	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	5.28e-05	0.000545	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCR5—type 2 diabetes mellitus	5.18e-05	0.000535	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	5.18e-05	0.000534	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—C3—type 2 diabetes mellitus	5.06e-05	0.000523	CbGpPWpGaD
Gentamicin—LRP2—Disease—PIK3R1—type 2 diabetes mellitus	5.04e-05	0.000521	CbGpPWpGaD
Gentamicin—LRP2—Disease—NOS3—type 2 diabetes mellitus	5.04e-05	0.000521	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	4.94e-05	0.00051	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	4.94e-05	0.00051	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PPARG—type 2 diabetes mellitus	4.91e-05	0.000507	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—HIF1A—type 2 diabetes mellitus	4.83e-05	0.000498	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.82e-05	0.000498	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IRS2—type 2 diabetes mellitus	4.82e-05	0.000497	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—INS—type 2 diabetes mellitus	4.82e-05	0.000497	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AGT—type 2 diabetes mellitus	4.81e-05	0.000497	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.8e-05	0.000495	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.77e-05	0.000492	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CALM1—type 2 diabetes mellitus	4.73e-05	0.000488	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—LEP—type 2 diabetes mellitus	4.71e-05	0.000487	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APOE—type 2 diabetes mellitus	4.71e-05	0.000487	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—APOA1—type 2 diabetes mellitus	4.66e-05	0.000481	CbGpPWpGaD
Gentamicin—LRP2—Disease—PTGS2—type 2 diabetes mellitus	4.61e-05	0.000476	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PRKCB—type 2 diabetes mellitus	4.45e-05	0.000459	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—ALB—type 2 diabetes mellitus	4.42e-05	0.000456	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PIK3R1—type 2 diabetes mellitus	4.22e-05	0.000436	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—NOS3—type 2 diabetes mellitus	4.22e-05	0.000436	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IRS1—type 2 diabetes mellitus	4.21e-05	0.000434	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	4.2e-05	0.000434	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—INS—type 2 diabetes mellitus	4.03e-05	0.000416	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.01e-05	0.000414	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CCL2—type 2 diabetes mellitus	3.96e-05	0.000409	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IGF1—type 2 diabetes mellitus	3.9e-05	0.000402	CbGpPWpGaD
Gentamicin—SLC22A6—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	3.9e-05	0.000402	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT2—type 2 diabetes mellitus	3.89e-05	0.000402	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—PTGS2—type 2 diabetes mellitus	3.86e-05	0.000399	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.84e-05	0.000397	CbGpPWpGaD
Gentamicin—LRP2—Disease—SRC—type 2 diabetes mellitus	3.73e-05	0.000385	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	3.7e-05	0.000382	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	3.53e-05	0.000365	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NOS3—type 2 diabetes mellitus	3.53e-05	0.000365	CbGpPWpGaD
Gentamicin—LRP2—Disease—TGFB1—type 2 diabetes mellitus	3.34e-05	0.000344	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—RELA—type 2 diabetes mellitus	3.32e-05	0.000343	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.31e-05	0.000342	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.3e-05	0.00034	CbGpPWpGaD
Gentamicin—LRP2—Disease—EGFR—type 2 diabetes mellitus	3.27e-05	0.000338	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.27e-05	0.000337	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.16e-05	0.000326	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—CASP3—type 2 diabetes mellitus	3e-05	0.00031	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	2.95e-05	0.000305	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—MMP9—type 2 diabetes mellitus	2.83e-05	0.000292	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—NFKB1—type 2 diabetes mellitus	2.8e-05	0.000289	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.66e-05	0.000275	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—SRC—type 2 diabetes mellitus	2.61e-05	0.00027	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—VEGFA—type 2 diabetes mellitus	2.54e-05	0.000263	CbGpPWpGaD
Gentamicin—LRP2—Disease—IL6—type 2 diabetes mellitus	2.51e-05	0.000259	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.5e-05	0.000258	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—TGFB1—type 2 diabetes mellitus	2.34e-05	0.000241	CbGpPWpGaD
Gentamicin—LRP2—Disease—AKT1—type 2 diabetes mellitus	2.32e-05	0.000239	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—EGFR—type 2 diabetes mellitus	2.29e-05	0.000236	CbGpPWpGaD
Gentamicin—SLC22A6—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	1.98e-05	0.000204	CbGpPWpGaD
Gentamicin—LRP2—Metabolism—AKT1—type 2 diabetes mellitus	1.94e-05	0.0002	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—IL6—type 2 diabetes mellitus	1.76e-05	0.000182	CbGpPWpGaD
Gentamicin—LRP2—Signaling Pathways—AKT1—type 2 diabetes mellitus	1.62e-05	0.000168	CbGpPWpGaD
